Objective To compare the effectiveness of part-time occlusion therapy(PTO) and observation in the treatment of intermittent exotropia(IXT). Methods An exhaustive search of the literature from Pubmed, EMBASE, Web of Science, and Cochrane Library databases was carried out until July 2022. No language restrictions were applied. The literature was rigorously screened against eligibility criteria. Weighted mean differences (WMD) and 95% confidence interval (CI) was calculated. Results A total of 4 articles with 617 participants were included in this meta-analysis. Our pooled results showed that PTO exhibited superior effects compared to observation, with greater decrease in exotropia control at distance and near (MD=-0.38, 95% CI: -0.57 to -0.20, P<0.001; MD=-0.36, 95%CI, -0.54 to -0.18, P<0.001), patients subjected to PTO therapy had greater decrease in distance deviations (MD=-1.95, 95% CI: -3.13 to -0.76, P=0.001). And there was greater improvement in near stereoacuity among PTO group in comparison with observation group (P<0.001). Conclusion The present meta-analysis indicated that part-time occlusion therapy showed a better effect in improving control and near stereopsis, and decreasing distance exodeviation angle of children with intermittent exotropia in comparison with observation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.